Cart
0

Hadoop-as-a-Service(HaaS) Market by Types(Run it Yourself RIY and Pure Play and End User manfacturing Industry, Retail Industry,Telecommunication Industry, media and Entertainment, Trade and Transportation and IT and ITES)- Global Opportunity Analysis and Industry Forecast,2013-2020

Get 20% Free Customization In This Report
LI_182116
Pages: 185
Jul 2018 | 1916 Views
 
Author's : Pallavi Jaiswal & Sohail Shaikh
Tables: 132
Charts: NA
 

Blood Pressure Monitoring Devices Market Overview:

Global Blood Pressure Monitoring Devices Market was valued at $ 1,981 million in 2015, and is anticipated to reach $ 2,926 million by 2022, registering a CAGR of 5.7% from 2016 to 2022. The demand for blood pressure monitoring devices is expected to increase in forthcoming years, as they can facilitate early diagnosis of a patients deteriorating health condition. In addition, advanced blood pressure monitoring devices are designed for personal use, which help to track the health status of a patient remotely.

Get more information on this report : Request Sample Pages

The demand for blood pressure monitoring devices is expected to increase globally during market analysis, owing to rise in incidence of chronic diseases and rapid increase in geriatric population. Moreover, increase in healthcare expenditure in emerging economies and high demand for proactive monitoring are expected to provide new opportunities for market players. However, lack of awareness in developing regions is anticipated to hamper the market growth.

Get more information on this report : Request Sample Pages

The BP monitoring devices market is segmented on the basis of product type and geography. On the basis of product type, the market is classified into aneroid BP monitors, digital BP monitors, blood pressure instrument accessories, and ambulatory BP monitors. Furthermore, geographical regions are categorized into, North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, Malaysia, and rest of Asia-Pacific), and LAMEA (Brazil, Middle East, Africa, and rest of LAMEA).

Get more information on this report : Request Sample Pages

The key players in the blood pressure monitoring devices industry have adopted product launch as their key developmental strategy to expand their market foothold. This is evident from the product launch of Masimo Corporations noninvasive blood pressure and temperature measurements for root patient monitoring and connectivity platform in the U.S. This helped clinicians to chart vital signs data directly from root automatically, and has strengthen the companys portfolio of patient monitoring products.

Get more information on this report : Request Sample Pages

Key players in the global blood pressure monitoring devices industry include A&D Company, Limited, Contec Medical Systems Co., Ltd., General Electric Company, Halma plc, Hill-Rom Holdings, Inc., Koninklijke Philips N.V., Masimo Corporation, Nihon Kohden Corporation, Omron Corporation, and Smiths Group Plc.

High blood pressure is a major cause of several diseases such as heart attack, stroke, and renal failure; thus, blood pressure monitoring is important to determine the severity of a patients condition. The increase in the adoption of blood pressure monitoring devices is due to increase in the incidence of cardiovascular diseases such as hypertension, risk of high BP in geriatric population, and expanding base of lifestyle diseases including obesity and diabetes.

Asia is one of the worlds highly populated countries and has emerged as an epicenter of COPD, diabetes, hypertension, and cardiovascular diseases epidemics. Therefore, the market for blood pressure monitoring devices in Argentina is projected to grow at a CAGR of 7.9% during the forecast period.

Key Benefits

  • This report entails a detailed quantitative analysis of the current blood pressure monitoring devices industry trends for the period of 2014 to 2022 to identify the prevailing opportunities.
  • The market estimations are based on comprehensive analysis of the key developments in the blood pressure monitoring devices industry.
  • The market is comprehensively analyzed with respect to product type, end user, and geography.
  • In-depth analysis of the size on the basis of geography helps in understanding the regional market to assist in strategic business planning.
  • The recent developments and strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Key Market Segments:

By Product Type

  • Aneroid BP Monitors
  • Digital BP Monitors
  • Blood Pressure Instrument Accessories
  • Ambulatory BP Monitors

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Indonesia
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Venezuela
    • Saudi Arabia
    • Republic of South Africa
    • Colombia
    • Argentina
    • Rest of LAMEA
 

Chapter 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/ TOP PLAYER POSITIONING, 2017
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter 4 CYTOGENETICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. Consumable

4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by product type

4.2.2.1. Testing kits, media, and reagents

4.2.2.1.1. Market size and forecast

4.2.2.2. Probes

4.2.2.2.1. Market size and forecast

4.2.2.3. Others(affinity reagents and stains)

4.2.2.3.1. Market size and forecast

4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country

4.3. Instrument

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Software & service

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

Chapter 5 CYTOGENETICS MARKET, BY TECHNIQUE

5.1. Overview

5.1.1. Market size and forecast

5.2. Comparitive genome hybridization

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Fluorescence in situ hybridization

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Karyotyping

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Immunohistochemistry

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

5.6. Others

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country

Chapter 6 CYTOGENETICS MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Genetic disorder

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Cancer

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. Personalized medicine

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

6.5. Other

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

Chapter 7 CYTOGENETICS MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Clinical and research laboratory

7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country

7.3. Pharmaceutical and biotechnology company

7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country

7.4. Academic Research Institute

7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country

7.5. Other

7.5.1. Market size and forecast, by region
7.5.2. Market analysis, by country

Chapter 8 CYTOGENETICS MARKET, BY REGION

8.1. OVERVIEW
8.2. NORTH AMERICA

8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast

8.2.2.1. U.S. market size and forecast

8.2.2.1.1. U.S. market size and forecast, by product
8.2.2.1.2. U.S. market size and forecast, by technique
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by end user

8.2.2.2. Canada market size and forecast

8.2.2.2.1. Canada market size and forecast, by product
8.2.2.2.2. Canada market size and forecast, by technique
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by end user

8.2.2.3. Mexico market size and forecast

8.2.2.3.1. Mexico market size and forecast, by product
8.2.2.3.2. Mexico market size and forecast, by technique
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by end user

8.2.3. North America cytogenetics market, by product
8.2.4. North America cytogenetics market, by technique
8.2.5. North America cytogenetics market, by application
8.2.6. North America cytogenetics market, by end user

8.3. EUROPE

8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast

8.3.2.1. Germany market size and forecast

8.3.2.1.1. Germany market size and forecast, by product
8.3.2.1.2. Germany market size and forecast, by technique
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by end user

8.3.2.2. France market size and forecast

8.3.2.2.1. France market size and forecast, by product
8.3.2.2.2. France market size and forecast, by technique
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by end user

8.3.2.3. UK market size and forecast

8.3.2.3.1. UK market size and forecast, by product
8.3.2.3.2. UK market size and forecast, by technique
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by end user

8.3.2.4. Italy market size and forecast

8.3.2.4.1. Italy market size and forecast, by product
8.3.2.4.2. Italy market size and forecast, by technique
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by end user

8.3.2.5. Spain market size and forecast

8.3.2.5.1. Spain market size and forecast, by product
8.3.2.5.2. Spain market size and forecast, by technique
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by end user

8.3.2.6. Rest of Europe market size and forecast

8.3.2.6.1. Rest of Europe market size and forecast, by product
8.3.2.6.2. Rest of Europe market size and forecast, by technique
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by end user

8.3.3. Europe cytogenetics market, by product
8.3.4. Europe cytogenetics market, by technique
8.3.5. Europe cytogenetics market, by application
8.3.6. Europe cytogenetics market, by end user

8.4. ASIA-PACIFIC

8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast

8.4.2.1. Japan market size and forecast

8.4.2.1.1. Japan market size and forecast, by product
8.4.2.1.2. Japan market size and forecast, by technique
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by end user

8.4.2.2. China market size and forecast

8.4.2.2.1. China market size and forecast, by product
8.4.2.2.2. China market size and forecast, by technique
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by end user

8.4.2.3. India market size and forecast

8.4.2.3.1. India market size and forecast, by product
8.4.2.3.2. India market size and forecast, by technique
8.4.2.3.3. India market size and forecast, by application
8.4.2.3.4. India market size and forecast, by end user

8.4.2.4. Australia market size and forecast

8.4.2.4.1. Australia market size and forecast, by product
8.4.2.4.2. Australia market size and forecast, by technique
8.4.2.4.3. Australia market size and forecast, by application
8.4.2.4.4. Australia market size and forecast, by end user

8.4.2.5. South Korea market size and forecast

8.4.2.5.1. South Korea market size and forecast, by product
8.4.2.5.2. South Korea market size and forecast, by technique
8.4.2.5.3. South Korea market size and forecast, by application
8.4.2.5.4. South Korea market size and forecast, by end user

8.4.2.6. Rest of Asia-Pacific market size and forecast

8.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
8.4.2.6.2. Rest of Asia-Pacific market size and forecast, by technique
8.4.2.6.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.6.4. Rest of Asia-Pacific market size and forecast, by end user

8.4.3. Asia-Pacific cytogenetics market, by product
8.4.4. Asia-Pacific cytogenetics market, by technique
8.4.5. Asia-Pacific cytogenetics market, by application
8.4.6. Asia-Pacific cytogenetics market, by end user

8.5. LAMEA

8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast

8.5.2.1. Brazil market size and forecast

8.5.2.1.1. Brazil market size and forecast, by product
8.5.2.1.2. Brazil market size and forecast, by technique
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by end user

8.5.2.2. Saudi Arabia market size and forecast

8.5.2.2.1. Saudi Arabia market size and forecast, by product
8.5.2.2.2. Saudi Arabia market size and forecast, by technique
8.5.2.2.3. Saudi Arabia market size and forecast, by application
8.5.2.2.4. Saudi Arabia market size and forecast, by end user

8.5.2.3. South Africa market size and forecast

8.5.2.3.1. South Africa market size and forecast, by product
8.5.2.3.2. South Africa market size and forecast, by technique
8.5.2.3.3. South Africa market size and forecast, by application
8.5.2.3.4. South Africa market size and forecast, by end user

8.5.2.4. Rest of LAMEA market size and forecast

8.5.2.4.1. Rest of LAMEA market size and forecast, by product
8.5.2.4.2. Rest of LAMEA market size and forecast, by technique
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by end user

8.5.3. LAMEA cytogenetics market, by product
8.5.4. LAMEA cytogenetics market, by technique
8.5.5. LAMEA cytogenetics market, by application
8.5.6. LAMEA cytogenetics market, by end user

Chapter 9 COMPANY PROFILES

9.1. Abbott Laboratories

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. Agilent Technologies, Inc.

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. Applied Spectrial Imaging, Inc.

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. Empire Genomics, LLC

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. Illumina, Inc.

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. Irvine Scientific

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. OPKO Health, Inc.

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. PerkinElmer, Inc.

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. Sysmex Corporation

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. Thermo Fisher Scientific, Inc.

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

 

Cytogenetics is a diverse field of genetics extensively employed for the study of chromosomes. The study of chromosomes help in the detection of genetic disorders arising due to chromosomal abnormalities. Thus, cytogenetics is applied for screening of genetic disorders such as cancer, cystic fibrosis, sickle cell anemia, and others. The growth of cytogenetics market is propelled by rise in incidence of cancer and genetic disorders. Furthermore, increase in awareness & acceptance of personalized medicines, growth in penetration of molecular cytogenetics in clinical pathological testing, and rise in focus on targeted cancer treatment are the key factors anticipated to boost the market growth in the near future.

The use of cytogenetics is highest in North America, owing to efforts taken by government and pharmaceutical companies towards the spread of awareness related to genetic disorders, followed by Europe and Asia-Pacific. Moreover, rise in prevalence of genetic disorders and presence of most of the major key players in this region contribute towards the growth of the market. In addition, instrument manufacturing companies have focused on expanding their presence in the emerging economies, which is anticipated to drive the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Hadoop-as-a-Service(HaaS) Market- Global Opportunity Analysis and Industry Forecast,2013-2020

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo